Co-Authors
This is a "connection" page, showing publications co-authored by PEIYING YANG and BEDRICH ECKHARDT.
Connection Strength
0.078
-
Eicosapentaenoic acid in combination with EPHA2 inhibition shows efficacy in preclinical models of triple-negative breast cancer by disrupting cellular cholesterol efflux. Oncogene. 2019 03; 38(12):2135-2150.
Score: 0.041
-
EGFR signaling promotes inflammation and cancer stem-like activity in inflammatory breast cancer. Oncotarget. 2017 Sep 15; 8(40):67904-67917.
Score: 0.037